Dr. Kelly L. Harms

Johann Gudjonsson, MD, PhD is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. A graduate of the University of Iceland Medical School, he completed his internship and dermatology residency training at the University of Michigan. Dr. Gudjonsson has served on the faculty of the University of Michigan Department of Dermatology since 2008. He provides general medical dermatology patient care at the University of Michigan Taubman Center and maintains clinical and research interests in inflammatory and autoimmune disorders involving the skin.Dr. Gudjonsson came to the U-M in 2003 as part of an innovative research residency training program. Building upon investigative dermatology training completed in Iceland, Dr. Gudjonsson has been performing basic immunological and genetic work on psoriasis at the U-M. Dr. Gudjonsson's primary research focus is basic immunological and genetic research on psoriasis, with projects directed at improving the diagnosis and treatment of psoriasis. He received the 2007 Young Investigator Award from the American Academy of Dermatology, was named the 2018 Rising Star Lecturer for the Society for Investigative Dermatology and was recipient of the American Skin Association Research Achievement Award in Psoriasis in 2021. Dr. Gudjonsson's research has been supported by research awards from the National Institutes of Health (NIH), the American Skin Association, Dermatology Foundation, Doris Duke Foundation, among others. Dr. Gudjonsson is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Benign Chronic Pemphigus, Psoriasis, Darier Disease, Cutaneous Lupus Erythematosus (CLE), and Vitrectomy. Dr. Gudjonsson is board certified in Dermatology. Dr. Gudjonsson is currently accepting new patients.

Dr. Christopher Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020. Dr. Bichakjian is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Eccrine Porocarcinoma. Dr. Bichakjian is board certified in Micrographic Dermatologic Surgery and Dermatology. Dr. Bichakjian is currently accepting new patients.

Dana A. Telem, MD, MPH, is the Section Head of General Surgery, the Associate Chair for Quality and Patient Safety, and the Lazar J. Greenfield Professor of Surgery. Dr. Telem completed her surgical training at The Mount Sinai Medical Center in New York and her fellowship in Minimally Invasive and Bariatric Surgery at the Massachusetts General Hospital. Dr. Telem also completed a Master’s in Public Health in the Executive Master’s of Healthcare Management program at the Columbia University Mailman School of Public Health.She serves on the editorial boards of Annals of Surgery and Surgery for Obesity and Related Diseases, is a Subject Editor for Surgical Endoscopy and a Section Editor for Hernia. Her research and commentaries have been published in several prominent journals such as the Journal of the American Medical Association (JAMA) and Annals of Surgery. She serves on the SAGES and Foundation for Surgical Fellowships Board of Governors, and holds key leadership positions across several organizations and societies focused on quality and patient safety, as well as diversity and inclusion.Clinical Specialization:Her clinical practice is devoted to minimally invasive therapies focused on hernia, benign diseases of the esophagus and morbid obesity. Dr. Telem is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Hernia, Obesity, Umbilical Hernia, Sleeve Gastrectomy, and Gallbladder Removal. Dr. Telem is board certified in Surgery. Dr. Telem is currently accepting new patients.